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Vaccinia virus complement control protein (VCP) is encoded by vaccinia virus, with its homolog encoded by other patho-
genic poxviruses including variola virus. Since rodents are the primary reservoir hosts of cowpox virus (CPV) and since
CPV encodes a highly conserved functional homolog of VCP, termed here the inflammation modulatory protein (IMP), the
effects of injection of CPV into the footpads of mice was determined in order to study the precise in vivo effects of IMP.
Macroscopic examination of the site of injection with a recombinant virus lacking IMP (CPV– IMP) showed greater tissue
damage, with more hemorrhage and induration, than sites injected with the wild-type cowpox virus. In addition, the measure-
ment of the specific swelling response carried out for several weeks revealed significantly greater swelling in mice injected
with CPV – IMP. Thus, IMP modulates the complement-activated inflammatory response in vivo. Furthermore, the diminished
destruction of host tissue observed in the presence of IMP indicates symbiosis in which the virus ensures the preservation
of surrounding host tissue, possibly to support the growth of its progeny. q 1997 Academic Press
INTRODUCTION includes, among others, complement receptor 1, comple-
ment receptor 2, C4b-binding protein, factor H, mem-
The complement system consist of more than 30 brane cofactor protein (MCP), and vaccinia virus comple-
plasma and membrane proteins that operate in a precise ment control protein (VCP).
sequence to eliminate invading microorganisms (Reid, Poxviruses are a complex group of highly successful
1995). Complement activation can occur by either of two pathogens that cause disease in humans and other ani-
major pathways, classical or alternative, with many pro- mals (Buller and Palumbo, 1991). Their genomes, in addi-
teins sharing structural and functional homologies be- tion to the proteins required for growth in cell culture,
tween the two. The proposed antiviral mechanisms of encode proteins which can either antagonize or compete
complement components include virus neutralization and with molecules critically involved in interacting with the
opsonization, lysis of virus-infected cells, and amplifica- host (Miller et al., 1995). These proteins are members
tion of inflammatory and specific immune responses of different viral protein families, consisting of the cell-
(Cooper, 1991). Complement is tightly regulated by multi- associated cytokine response-modifying (Ray et al., 1992)
ple complement-regulatory proteins which control activa- or serpin-related (Kotwal and Moss, 1989) protein family
tion of the complement defense system and regulate and the secretory protein (virokine) family, which includes
generation of the chemotactic fragments, C3a, C4a, and a complement control protein (Kotwal and Moss, 1988), a
C5a. These peptide fragments induce a local inflamma- neurovirulence factor (Kotwal et al., 1989), and a group
tory response by activating cells to release mediators of cytokine-binding proteins (viroreceptors) (Upton et al.,
that induce smooth muscle contraction and increase vas- 1992). While vaccinia virus (VV) is the best-characterized
cular permeability. One large complement-regulatory member of the orthopoxvirus family, rodents are not a
family consists of proteins made up of 4– 30 short con- natural reservoir for VV. Therefore, although experiments
sensus repeats (SCRs),2 each of which is a 60- to 70- using VV in rodents have in the past provided valuable
amino-acid-long repeat (Krych et al., 1992). This family information, they do not correlate to VV or variola virus
infection in humans. Since rodents are natural reservoirs
for cowpox virus (CPV), they serve as an optimal and1 To whom correspondence and reprint requests should be ad-
practical model system for simulating a natural infection.dressed at Department of Microbiology and Immunology, University of
Vaccinia virus complement control protein (VCP) wasLouisville School of Medicine, Louisville, KY 40292. Fax: (502) 852-7531.
E-mail GJKOTW01@ULKYVM.LOUISVILLE.EDU. the first soluble microbial protein to have been shown to
2 Abbreviations used: SCR, short concensus repeat; VCP, vaccinia be structurally similar to mammalian complement control
virus complement control protein; IMP, inflammation modulatory pro- proteins (Kotwal et al., 1989). The four short consensustein; VV, vaccinia virus; CPV, cowpox virus; VAR, variola virus; SSR,
repeat sequences of VCP show the greatest similarity tospecific swelling response; MCP, membrane cofactor protein; wild-
type, wt; CAM, chorioallantoic membrane. the human C4b-binding protein (hC4b-BP) (Kotwal and
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Moss, 1988). Purified VCP was biologically active and were also purchased from the Jackson Laboratory. Ge-
netic analysis of B10.D2/oSnJ C5-deficient mice showedwas shown to bind to C3 and C4, to block the comple-
ment cascade at multiple sites (Kotwal et al., 1990; Mc- that they were incapable of producing active C5 (Wetsel
et al., 1990). All animals were maintained according to theKenzie et al., 1992), to block complement-mediated anti-
body-enhanced neutralization in vitro and cause more University of Louisville IACUC guidelines. The Brighton
strain of cowpox virus was obtained as described earlierrapid healing of skin lesions in rabbits (Isaacs et al.,
1992), and to exhibit greater potency than the natural (Miller et al., 1995). The recombinant cowpox virus lacking
IMP was constructed as described below.human complement control proteins (Kotwal, 1994).
Therefore, VCP is functionally similar to soluble comple-
Sequencing of the homolog of IMP of cowpox virusment receptor 1 (sCR1), which has complement inhibitory
and anti-inflammatory activities (Weisman et al., 1990). A Cowpox virus strain GRI-90 (CPV) DNA was hydrolyzed
protein with 100% identity to VCP of the WR strain (Kotwal by HindIII and fragments were ligated to HindIII-digested
and Moss, 1988) is also encoded by the Copenhagen pUBS19. The ligation mixture was used to transform com-
strain of vaccinia virus (Massung et al., 1993). In addition, petent Escherichia coli cells (strain JM109) by standard
a highly conserved homolog of VCP is also encoded by protocols (Maniatis et al., 1990). Hybrid plasmid con-
at least two strains of smallpox virus (Massung et al., taining the HindIII-D fragment of the CPV genome was
1993; Shchelkunov et al., 1993) and, as reported here, by used for sequencing. The method of Maxam and Gilbert
cowpox virus, underscoring the widespread importance (1980), with minor changes, was used. Sequence data
of VCP in virus – host interaction. Furthermore, the critical have been deposited with the EMBL Data Library under
importance of the initial complement-mediated host in- Accession No. X94355.
flammatory response due to mononuclear cell infiltration
elicited by cowpox virus (CPV) was recently demon- Construction of recombinant CPV-IMP
strated in vivo (Miller et al., 1995). It had been shown
Plasmid pGK10, containing the entire ORF for VCPpreviously that the cowpox inhibitor (crmA) of the IL-1b-
within the HindIII– BamHI portion of the HindIII-C frag-converting enzyme (ICE) in vitro was involved in regulat-
ment of vaccinia virus DNA cloned in pUC19, wasing the inflammatory response in chicken embryo chorio-
cleaved with EcoRV and resulted in the excision of onlyallantoic membrane (Ray et al., 1992). However, the lack
70 bp within the ORF of the VCP gene. A gpt cassetteof influence of crmA on the complex inflammatory re-
(containing the E. coli gpt gene under the control of thesponse in a mouse model, which has a well-developed
vaccinia P7.5 promoter) was excised from plasmidcomplement system, may indicate that the cytokine regu-
pTK61-gpt (Falkner and Moss, 1988) by digestion withlation may be complement C5 dependent. There is also
EcoRI and inserted within the VCP ORF after the endsa possibility that the effects observed by crmA may be
were filled in with the Klenow fragment of DNA polymer-redundant in view of the fact that crmA-defective mutants
ase. This yielded plasmid pGK12. CV-1 cells infected withmay still encode a secreted IL-1 receptor. Nonetheless,
CPV were transfected with pGK12. Recombinant cowpoxin a host with a well-developed immune system, the com-
virus was isolated by three rounds of plaque purificationplement system may be one of the most important well-
in selective medium. The resulting plaque-purified myco-regulated primary defense against orthopox viruses.
phenolic acid-resistant virus vSIGK5, termed here CPV–We report here that cowpox IMP modulates comple-
IMP, was amplified to high titer.ment-activated inflammatory responses in vivo and con-
tributes to active evasion of host defense as well as
Inhibition of complement-mediated immune hemolysis
diminished damage of host tissue. The absence of IMP
of sheep RBC
causes an increase in the specific swelling response,
which is accompanied by induration and hemorrhage. The complement-inhibitory activity of the cell culture
media was measured by standard procedures and usingComparisons of the IMP sequences of various poxvi-
ruses are also presented, along with comparisons to the following commercially available materials. Sensi-
tized sheep red blood cells (Diamedix, Miami, FL) in 150-several mammalian C4b-BPs. This indicates a high de-
gree of conservation among viruses and a close similar- ml volumes were dispensed into the wells of a 96 - Micro-
well plate (Nunc, Inc., Naperville, IL). A blank was pre-ity to each of the mammalian C4b-BPs.
pared by adding 50 ml of diluent (gelatin veronal buffer,
Sigma, St. Louis, MO) to the first well. A reference stan-MATERIALS AND METHODS
dard was prepared by adding 5 ml of a 1:20 diluted stan-
Mice, viruses, and antibody
dard serum (Diamedix) and 45 ml of diluent. Varying
amounts of the respective media, 5 ml of 1:20 dilutedBALB/c (6 male, 6 female) mice 6– 8 weeks of age were
purchased from the Jackson Laboratory (Bar Harbor, ME). standard serum, and 30 ml of diluent were added to the
test well. The contents of the wells were mixed, and theThe B10.D2/nSnJ (C5-sufficient) and B10.D2/oSnJ (C5-defi-
cient) (14 male, 14 female) mice, 6– 8 weeks of age, quality plate was incubated at 377 for 1 hr. The samples were
withdrawn from the wells and centrifuged in microfugecontrolled for phenotype by testing for hemolytic activity,
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2 B10.D2/oSnJ) were injected with the same volume oftubes. The supernatants were transferred to a flat-bottom
phosphate-buffered saline (PBS). Injections of CPV, CPV–microplate, and absorbance was measured at 415 nm.
IMP, or PBS were done in both male and female age-The percent inhibition of hemolysis was calculated by
matched mice of the same strain. Footpads were mea-deducting the percent hemolysis from 100%.
sured on alternate days using an engineer’s micrometer
(Miller et al., 1995). Specific footpad swelling responsesFootpad injection
were obtained by subtracting the footpad thickness mea-
A total of 40 mice were used in this study. The right sured before injection of the virus in individual mice.
footpads of 34 mice (10 BALB/c, 12 B10.D2/nSnJ, 12
RESULTSB10.D2/oSnJ) were injected sc with 106 PFU of gradient-
Location and sequence of the IMP genepurified CPV or cowpox virus mutant lacking the IMP gene
(CPV– IMP) in a 25-ml volume, using a 25-gauge needle. To determine whether the genome of CPV encoded
an ORF similar to the ORF for VCP in vaccinia virus, weSix other identical control mice (2 BALB/c, 2 B10.D2/nSnJ,
FIG. 1. Sequence and functional characterization of IMP of CPV. (A) A photograph of an agarose gel of the PCR products using the underlined
primers shown in B. Lane 1, vaccinia virus; 2, cowpox virus. (B) Nucleotide sequence of the IMP ORF. The predicted amino acid sequence is shown
with amino acids using the single-letter code along with the corresponding DNA sequence. The oligonucleotide sequences used to generate the
primers are single underlined and the EcoRV site is doubled underlined. The four SCRs are also identified with Roman numerals I, II, III, and IV.
(C) Percent inhibition of lysis of sensitized sheep red blood cells in the presence of human serum complement by media from CPV- and CPV– IMP-
infected CV-1 cultures.
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ences between CPV and VV/VAR are revealed in the first
SCR (Fig. 2A). Manual multiple alignment of IMP and
mammalian complement 4b binding proteins indicates
that 21% of the amino acids are indentical in all four
sequences (Fig. 2B). There is a greater proportion of
identical amino acids (37%) shared by the bovine C4b-
BP and IMP than either the human (35%) or the mouse
(30%) C4b-BPs and IMP, indicating that the bovine C4b-
BP and IMP are the closest.
Characterization of recombinant CPV– IMP
Although the recombinant cowpox virus lacking the
homolog of VCP, referred to here as CPV– IMP, was used
earlier to determine the influence of the homolog of VCP
on CAM (Palumbo et al., 1994), it was not characterized
to ensure that it is no longer expressing any protein that
can block the complement-mediated hemolytic activity of
sensitized sheep RBCs. In order to prove that CPV does
express a functional complement inhibitory protein and
CPV– IMP does not, a previously described hemolysis
assay was performed (Kotwal et al., 1990). As can be
seen from Fig. 1C, medium from CPV is able to block
hemolysis in a linear fashion, whereas medium from
CPV– IMP is unable to do so under identical conditions.
Thus, CPV has a functional complement control protein,FIG. 2. Comparison of the sequence of IMP with other related pox-
while CPV– IMP does not.viral proteins and C4b-BPs. (A) Optimal sequence alignment of IMP of
cowpox virus (CPV), vaccinia virus-WR (VV), variola virus-Bangladesh
(BSH), variola virus-Garcia (GAR), variola virus-India (IND). Dashes indi- Complement levels of mice
cate identical amino acids; an asterisk indicates a potential glycosyla-
Three different strains of mice were used in this study,tion site. The four SCRs are identified with Roman numerals I, II, III,
and IV. (B) Optimal sequence alignment of IMP to the first four SCRs B10.D2/nSnJ, B10.D2/oSnJ, and BALB/c. Levels of com-
of mammalian complement 4b-binding proteins. Cowpox virus (CPV), plement components vary in each strain of mice. Conge-
bovine C4b-BP (BC4), human C4b-BP (HC4), murine C4b-BP (MC4). nically matched C5-sufficient B10.D2/nSnJ (wild-type lev-Colons indicate identical amino acids; small letters refer to conserva-
els of C5) and C5-deficient B10.D2/oSnJ (no C5) micetive similarities.
were used because of our previous work showing the
importance of complement C5 in poxvirus infections
(Miller et al., 1995). B10.D2/oSnJ mice are unable to pro-used primers derived from the terminal regions of the
duce functional C5 (Wetsel et al., 1990). BALB/c miceVCP open reading frame to amplify by PCR VAC-WR and
have low levels of C3 (Dieli et al., 1988).CPV-Brighton DNA. The results show that a DNA of iden-
tical size is amplified (Fig. 1A). The intensity is also simi-
Specific swelling response in different mouselar, indicating a high degree of similarity in the primer
systems with varying complement levelsregion. In order to confirm the presence of an ORF and
to ensure that no significant differences existed within As seen in Fig. 3A, CPV-IMP elicited a considerable
the flanking region, sequence analysis of the HindIII-D footpad swelling response after injection into C5-suffi-
fragment of CPV was performed by a previously de- cient footpads, with the peak response occurring around
scribed procedure (Shchelkunov et al., 1993). Predicted the tenth day. The footpad response elicited by CPV–
amino acid sequences were compared with the Swiss- IMP was greater than that elicited with CPV alone (Fig.
Prot Protein Sequence Database (release 3.1). The open 3A). This suggests that IMP has an impact on the magni-
reading frame (ORF) D17L of CPV (Fig. 1B) was identified tude of, or exerts control over, the inflammatory response
as the homolog of the VCP of vaccinia (VV) and variola elicited in response to the virus infection. High precision
viruses (VAR). In addition, the sequences flanking the was observed; note the extremely small standard devia-
ORF were similar in CPV and VV. We have carried out tions, which clearly indicate that the outcome will not
comparisons of the sequence of this CPV ORF with other change even if many more animals are used in the exper-
homologous orthopoxviral proteins and with mammalian iment. Furthermore, the response with CPV– IMP was so
C4b-BPs (Fig. 2). It can be seen that the IMP of CPV has intense that the footpads and other parts of the foot were
high identity with homologous proteins of variola and greatly enlarged and became ulcerated after 6 days of
infection (data not shown). By contrast, under similar con-vaccinia viruses, although a number of amino acid differ-
AID VY 8396 / 6a28$$$881 01-31-97 17:10:37 viral AP: Virology
130 MILLER, SHCHELKUNOV, AND KOTWAL
FIG. 3. Footpad swelling responses of mice to virus infections. Twenty-four C5-sufficient (A) or C5-deficient (B) mice were injected with cowpox
virus (CPV) or cowpox virus minus IMP (CPV – IMP) (12 mice each) sc into the right footpad in 25 ml of PBS. Mice received 1 1 106 PFU CPV or
CPV– IMP. Response of the four control mice injected with 25 ml of PBS alone is also shown. Footpad thickness for all mice in each of the groups
was measured before injection and subtracted to obtain specific footpad swelling responses. The specific swelling response plotted against the
number of days is shown. Significant standard deviations are shown with bars.
ditions, the CPV-mediated footpad swelling response swelling response (SSR) to the virus (Fig. 4A) and had
intact toes (Fig. 4B). This suggests that IMP also regu-was not accompanied by gross enlargement (swelling)
of the foot, nor was it accompanied by severe ulceration lates the immune response through C3, since it is able
to modulate the low C3 levels in the BALB/c mice.or distortion of the toes. The data collectively indicate
that the degree of severity of the inflammatory response
elicited following footpad inoculations of CPV is depen- DISCUSSION
dent on IMP. Thus, the presence or absence of IMP
appears to have a profound effect on the magnitude of Microorganisms have long been known to evade the
the inflammatory response elicited by the cowpox virus. host defense by passive mechanisms such as antigenic
When C5-deficient mice were injected with the same variation, genomic integration, and residing in sites not
virus PFU’s as congenically matched C5-sufficient mice, accessible to immune surveillance. It is now becoming
an increase in the ulceration, hemorrhaging, and indura- increasingly evident that microorganisms encode pro-
tion occurred. This concurs with our previous study that teins which mimic immune defense molecules (Kotwal,
C5 plays an important role in the host response elicited, 1996). This more aggressive mechanism, also referred
possibly because C5a determines the type of immune to as an active mechanism, allows microorganisms to
cells that are recruited at the site of injection. However, downregulate the host immune system (Miller et al.,
CPV– IMP still elicited a higher SSR than did CPV (Fig. 1995). Recently, there have been several reports indicat-
3B), showing that IMP can regulate the immune response ing that the downregulation of the immune system can
before C5 exerts its effects. also occur in the intracellular biosynthetic processing of
Since IMP is proposed to act through C3 or C4, it was cytokines such as IL-1b (Ray et al., 1992) and the pro-
of importance to investigate the response of mice with cessing of MHC class I (Browne et al., 1990) and class
low levels of C3 to cowpox virus infection. BALB/c mice II (Spriggs et al., 1996).
injected with CPV– IMP had to be humanely sacrificed The microbial defense molecules that mediate the im-
at Day 12 because the footpad was swollen to three munomodulation and evasion of the host defense often
times its original size and there was severe necrosis of have structural and functional similarity to either comple-
the footpad tissue, including fusion of toes (Fig. 4B). ment-regulatory proteins, serpin superfamily proteins, cy-
tokines, or cytokine receptors. An exceptional exampleBALB/c mice injected with CPV had a less severe specific
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FIG. 4. Footpad swelling responses of mice to virus infections. (A)
Ten BALB/c (low C3) mice were injected with cowpox virus (CPV) or
cowpox virus minus IMP (CPV– IMP) (five mice each) sc into the right
footpad in 25 ml of PBS. Mice received 1 1 106 PFU CPV or CPV –IMP.
Response of two control mice injected with 25 ml of PBS alone is also
shown. Footpad thickness for mice in each of the groups was measured
before injection and subtracted to obtain specific footpad swelling re-
sponses. The specific swelling response plotted against the number of
days is shown. Significant standard deviations are shown with bars. (B)
Photographs showing the appearance of footpads at peak SSR upon
injection of BALB/c mice with (A) PBS, (B) CPV, and (C) CPV –IMP.
of molecular mimicry is VCP, which has structural and
functional similarity to complement control proteins such
as C4b-binding protein, factor H, MCP, decay accelera-
tion factor (DAF), properdin, complement receptor 1
(CR1), etc. (Kotwal and Moss, 1988). Since in vivo data
on infection of normal and C5-deficient mice with CPV
supported the view that complement does play a signifi-
cant role in the initial response to poxviral infection
(Miller et al., 1995) and since there have been very few
studies characterizing the precise in vivo mechanism of
action of the putative microbial defense molecules, this
study was designed to investigate the interactions of the
cowpox homolog of VCP, termed here the inflammation
modulatory protein or IMP, at the site of infection. Mice
with varying levels of complement components (BALB/c
mice, congenic C5-deficient mice, and C5-sufficient
mice) were injected sc in the footpad with CPV or a
recombinant virus lacking IMP, termed CPV– IMP. Mac-
roscopic examination of the site of injection and the mea- FIG. 4—Continued
surement of the SSR was carried out at frequent intervals
for several weeks to quantitate the extent of the inflam- downregulating the formation of chemotactic peptides
C3a, C4a, and C5a, which would otherwise coat virusmatory response. Mice which had been injected with
CPV– IMP exhibited severe pathology and a significantly particles and target them for CR1-containing phago-
cytic cells. The lack of a role in the regulation of thegreater SSR than the mice injected with the wt CPV.
As shown in Fig. 5, the regulation of the major com- formation of MAC or the terminal lytic complement
pathway by IMP has been previously confirmed in vitroplement activation pathways by IMP is dependent on
the stoichiometry of the host complement components. (Meri and Kotwal, unpublished). Thus, the multiple ef-
fects of IMP are centered around the downregulation ofIn congenic C5-deficient mice, the observed differ-
ences in severity can be attributed to the effects of complement components and of chemotactic peptides
arising from C3. To test this hypothesis, BALB/c (lowIMP prior to the lytic pathway. IMP most likely acts
by sequestering C3 and C4 through binding, thereby C3) mice were used to determine whether the effects
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the recombinant CPV– IMP suggested that the IMP
was able to downregulate the inherently low C3 levels.
The chick embryo chorioallantoic membrane (CAM)
system has been extensively used to study the influence
of various individual and combinations of poxviral pro-
teins (Palumbo et al., 1994) on the host inflammatory
response and has provided valuable information. How-
ever, since the chicken embryo does not have a well-
developed complement system, the CAM system is not
appropriate for the study of the inflammatory response
elicited by IMP. We therefore developed a mouse footpad
model because it offers a fully developed complement
system, allows for retention and growth of the virus at
a specific site, and offers an opportunity to accurately
measure the degree of swelling, providing an easy and
direct measurement of the degree of inflammatory re-
sponse. Therefore, the true importance of evaluating the
contribution of individual immunomodulatory proteins
can only be achieved by using a model consisting of a
matched host that has a complete and well-developed
immune response against the viral infection.
The observed diminished destruction of host tissue in
the presence of IMP indicates an amazing synergy in
which the virus ensures the preservation of surrounding
host tissue, thus allowing host cells to support viral
growth and prevent extinction. This theme parallels the
role of the epidermal growth factor-like poxviral protein,
which supports proliferation of uninfected host cells adja-
cent to infected cells, described earlier (Buller et al.,
1988). This suggests that the differences seen in the
pathogenesis of various poxviruses are due to the differ-
ences in the overall host response. The role of IMP may
therefore be to regulate the innate host response. The
type of immune response elicited by a host against a
microorganism may often be directed by the microorgan-
isms. Poxviruses need to replicate to high titers very
rapidly while evading the innate response and then find
new hosts prior to the manifestation of the adaptive re-
sponse. It is also possible that the type of cells (neutro-
phils or macrophage) reaching the site of infection may
be influenced by the chemotactic factors released locally
and which in turn may be regulated by the viral encoded
immunoregulatory proteins expressed during infection.
Furthermore, for chronic persistent viruses like HIV, HCV,
and HBV, the purpose may be to persistently infect the
one host and therefore complement may play a minimal
role, if any, and this may be why cytokine administration
(e.g., IFN-a) has been found to be essential for reducing
viremia.
FIG. 5. Complement pathways in normal (C5-sufficient), C5-deficient, In summary, IMP plays a significant role in the immu-
and BALB/c mice. The asterisk shows point of inhibition. Shaded areas
nomodulation of the complement-activated inflammatoryindicate areas in which the complement pathway is either partially
responses of the host. This protein, conserved in several(gray) or completely (black) blocked.
orthopoxviruses, was originally acquired from the host
and was then extensively modified and shortened to re-
tain the very minimal and yet the most essential regionsof IMP would be more significant in the presence of
lower levels of C3. The higher degree of severity of of the complex host complement-regulatory proteins. For
instance, the C4b-binding protein, to which IMP is mostinflammation observed in BALB/c mice injected with
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polypeptide structurally related to complement control proteins. Na-similar, is a giant spider-like molecule consisting of sev-
ture 335, 176– 178.eral reactive subunits but it is not as potent as IMP. The
Kotwal, G. J., and Moss, B. (1989). Vaccinia virus encodes two proteins
understanding of this clever evasion mechanism should that are structurally related to members of the plasma serine prote-
serve as a model and provide an impetus for studying ase inhibitor superfamily. J. Virol. 63, 600 –696.
Krych, M., Atkinson, J. P., and Holers, V. M. (1992). Complement recep-the strategies of other microbial defense molecules.
tors. Curr. Opin. Immunol. 4, 8– 13.
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